Press Releases Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Market Closed - OTC Markets Other stock markets 11:57:35 2024-05-08 am EDT			5-day change	1st Jan Change
1.365 ^USD	-2.54%		-2.54%	-35.00%

May. 08	Relief Therapeutics Restructures Management Team, Creates New Roles	MT
May. 08	Relief Therapeutics Announces Executive Changes	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

RELIEF THERAPEUTICS Holding SA to Hold Extraordinary General Meeting	Mar. 28	AQ
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria	Mar. 22	AQ
Relief Therapeutics Shifts Commercial Operations to Partnership Model, Focusing on Efficient Patient Access and R&D Growth	Dec. 06	AQ
Relief Therapeutics Announces CEO Transition	Nov. 23	AQ
Relief Therapeutics announces that more than 400,000 of its ADRs are currently outstanding and that, as a result, the Company has achieved an Important NASDAQ Initial Listing Milestone	23-10-11	AQ
Relief Therapeutics Reports Half-Year 2023 Financial Results and Provides Corporate Update	23-09-18	AQ
RELIEF THERAPEUTICS Holding SA Announces CHF 5 Million Private Placement	23-06-19	AQ
Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares	23-05-03	EQ
Relief Therapeutics Announces Collaboration Partner Reports OLPRUVA™ Commercial Launch Progressing Ahead of Schedule	23-05-01	EQ
Relief Therapeutics Announces Results of Extraordinary General Meeting of Shareholders	23-04-28	EQ
Relief Therapeutics Announces Positive 12-Month Stability Data for Inhaled and Intravenous Preparations of RLF-100	23-04-17	EQ
Relief Therapeutics Announces Full Year 2022 Financial Results and Provides Corporate Update	23-04-14	EQ
Relief Therapeutics Announces Executive Leadership Team Change	23-04-05	EQ
Relief Therapeutics Holding SA to Hold Extraordinary General Meeting of Shareholders	23-04-04	EQ
Relief Therapeutics Appoints World-Renowned Gene Therapy Pioneer Guangping Gao, Ph.D. as Chair of Scientific Advisory Board	23-04-03	EQ
Relief Therapeutics Announces Survey Results Identifying Preferred Urea Cycle Disorder Treatment Attributes Presented by Collaboration Partner at SIMD 2023	23-03-22	EQ
Relief Therapeutics to Present Pre-Clinical Evidence for Improved Amino Acid Utilization with PKU GOLIKE at the Society for Inherited Metabolic Disorders 44th Annual Meeting	23-03-17	EQ
Relief Therapeutics Announces Availability of New PKU GOLIKE BARs in Europe	23-03-16	EQ
Relief Therapeutics Provides Update From Collaboration Partner on OLPRUVA™	23-03-15	EQ
Relief Therapeutics Recognizes Rare Disease Day and Announces U.S. Availability of New PKU GOLIKE Bars	23-02-28	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Relief Therapeutics Holding SA OTC Markets

Equities

RLFTY

US7595JP3044

Press Releases

Filters